Gainers & Losers
Fri Dec 05 2025 10:28:00- State Bank of India share price
- ₹971.402.46%
- Bajaj Finserv share price
- ₹2,092.802.08%
- Bajaj Finance share price
- ₹1,048.451.89%
- Maruti Suzuki India share price
- ₹16,285.001.80%
- HCL Technologies share price
- ₹1,682.851.68%
Active Stocks
Fri Dec 05 2025 10:24:04- Suzlon Energy share price
- ₹51.751.77%
- Yes Bank share price
- ₹22.60-0.75%
- Canara Bank share price
- ₹148.550.88%
- Punjab National Bank share price
- ₹121.701.80%
- Adani Power share price
- ₹143.750.70%
Business News/Market/Market Stats/Senores Pharmaceuticals share price/ Senores Pharmaceuticals Profit Loss Annual
Senores Pharmaceuticals Profit & Loss Annual
777.40 -6.85 (-0.87%)Updated : 05 Dec 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 325.39 | 182.92 | 24.29 | 12.92 |
| Other Net | 7.49 | 1.75 | 0.26 | 0.46 |
| Diluted Weighted Average Shares | 3.64 | 3.33 | 3.33 | 3.33 |
| Gain( Loss)on Saleof Assets | 0.00 | -0.03 | -0.16 | - |
| Depreciation/ Amortization | 16.84 | 10.02 | 1.78 | 0.71 |
| Operating Income | 72.86 | 31.61 | 11.05 | 1.25 |
| Net Income | 58.56 | 31.46 | 8.43 | 0.99 |
| Income Availableto Com Excl Extra Ord | 58.56 | 31.46 | 8.43 | 0.99 |
| Other Operating Expenses Total | 39.10 | 21.72 | 4.50 | 1.24 |
| Net Income Before Taxes | 70.57 | 24.94 | 12.44 | 1.14 |
| Minority Interest | 0.22 | -1.25 | - | - |
| Net Income After Taxes | 58.34 | 32.71 | 8.43 | 0.99 |
| Income Availableto Com Incl Extra Ord | 58.56 | 31.46 | 8.43 | 0.99 |
| Costof Revenue Total | 195.98 | 111.57 | 12.77 | 8.03 |
| Gross Profit | 202.27 | 102.96 | 22.57 | 6.14 |
| Interest Inc( Exp) Net- Non- Op Total | -9.78 | -8.38 | 1.28 | -0.57 |
| Diluted Net Income | 58.56 | 31.46 | 8.43 | 0.99 |
| Provisionfor Income Taxes | 12.23 | -7.76 | 4.00 | 0.15 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 58.56 | 31.46 | 8.43 | 0.99 |
| Total Revenue | 398.25 | 214.52 | 35.34 | 14.17 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 398.25 | 214.52 | 35.34 | 14.17 |
| Selling/ General/ Admin Expenses Total | 72.98 | 39.62 | 5.24 | 2.95 |
| Diluted Normalized EPS | 16.10 | 9.46 | 2.57 | 0.30 |
| Research Development | 0.49 | - | - | - |
| Diluted EPS Excluding Extra Ord Items | 16.10 | 9.46 | 2.54 | 0.30 |
*All figures in crores except per share values
Senores Pharmaceuticals Quick Links
Senores Pharmaceuticals Dividend Senores Pharmaceuticals Bonus Senores Pharmaceuticals News Senores Pharmaceuticals AGM Senores Pharmaceuticals Rights Senores Pharmaceuticals Splits Senores Pharmaceuticals Board Meetings Senores Pharmaceuticals Key Metrics Senores Pharmaceuticals Shareholdings Senores Pharmaceuticals Balance Sheet Senores Pharmaceuticals Cashflow Senores Pharmaceuticals Q1 Results Senores Pharmaceuticals Q2 Results Senores Pharmaceuticals Q3 Results Senores Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
972.00+23.95(2.53%)
2,094.80+44.60(2.18%)
16,308.00+310.80(1.94%)
2,341.10-82.90 (-3.42%)
292.30-3.50 (-1.18%)